AlphaCentric Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

AlphaCentric Advisors’s Portfolio ARQT Stock Details ARQT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$876K	Sell
2023 Q2	$2.79M	Buy
2023 Q1	$2.09M	Buy
2022 Q4	$1.16M	Buy
2021 Q4	$1.09M	Buy
2021 Q3	$848K	Buy
2021 Q2	$368K	Buy
2021 Q1	$347K	Buy